With the use of Hedera Dx's liquid biopsy solution, hospital labs will be able to conduct clinically useful liquid biopsies on their own. This will greatly simplify tumor profiling. It is difficult to accomplish IVD compliance, privacy infrastructure, and validation, and even if these challenges are overcome, the current software workflows areinefficient to use and lack key capabilities.Hedera Dx was established on July 1, 2021 in Epalinges, Vaud.

Health Care

Hedera Dx

Tommi Lehtonen

Sanga Mitra Boppudi

Damien Lapray

Christian Meisel

Juha Salonen

Elodie Caroti Francisco

Paola Castelli

Thomas Vetterli

Kaarlo Haikonen

Valentin Matillon

Engineering and Software Development

Leadership Team

Teams at Hedera Dx

Engineering and Software Development

Leadership Team